SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Guilford (GLFD) - Steadily Rising

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Steve who wrote (183)2/12/1998 11:39:00 AM
From: bill small  Read Replies (1) of 496
 
Steve, I looked too at the analyst reports and always do before investing in biotech since I have limited expertise at evaluating the technology. The thing I find most useful is the financial models of revenue/earnings they make from their eveluations of the pipeline, technology and markets for each product.

From the reports of several analysts of GLFD, it would appear that the stock is a great buy now. I can't find a major flaw in their conclusion about things. So I am buying stock now. Of course there is a risk of GLFD falling on their face in many areas of research as well as markets for products not materializing as projected, but this is true with any biotech stock.

I think most of price weakness is due to biotech being out of favor for now, But this is starting to turn around some in the last week or so and as sentiment turns for the sector, GLFD should return to former levels at a minimum. From there I see it trading more on developments in its programs.

Are you a GLDF holder?

best of luck......Bill
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext